Carboxymethyl Starch as a Pharmaceutical Excipient: A Comprehensive Review of its Synthesis, Properties, and Multifunctional Applications in Drug Delivery

The Evolution from Native Starch to A Versatile Pharmaceutical Polymer

Starch is a natural polysaccharide produced by plants and is recognized as a renewable, abundant, and cost-effective biopolymer for industrial applications.^2,3,8 It is derived from a variety of plant sources such as corn, wheat, potatoes, and cassava and has served as a common excipient (filler, binder, and disintegrant) for oral solid dosage forms within the pharmaceutical industry for many decades. However, the use of native starch in the formulation of modern, high-performance drug delivery systems has been limited by many of the physicochemical deficiencies associated with native starch as it exists today.^3,4,5The present review paper provides information about how to make this compound via a chemical reaction called carboxymethylation, it is explained that the conditions of the reaction will have a significant effect on the Degree of Substitution (DS) of CMS which ultimately determines the physical and functional properties associated with CMS.^2,4,15The review covers many different uses of CMS, such as its primary use as a super-disintegrant in immediate release solid dosage forms (Sodium Starch Glycolate) and also its use as a binder/thickener/stabilizer in many different types of formulations.^2,3,4,13 The review primarily focuses on describing the mechanisms for rapid disintegration of tablets; specifically, it describes how these mechanisms act together to produce tablet fragmentation through the interaction of swelling and electrostatic repulsion.^2,4,13Finally, the review provides a novel method to utilize CMS for "smart" delivery systems for drugs. The ability of CMS to respond due to its pH levels and mucoadhesive nature allows for targeted drug delivery. The review compares CMS with other widely used excipients, reviews important variables related to formulation/manufacturing processes as well as regulatory and safety profiles of CMS according to the major pharmacopeias confirming the versatility and need of CMS as a valuable tool in the development of pharmaceutical products.

1. Synthesis and Molecular Characterization of Carboxymethyl Starch

The transformation of native starch into Carboxymethyl Starch is a well-established chemical process that allows for the precise tuning of the polymer's final properties.^{1, 3} The success of this modification hinges on a deep understanding of the underlying reaction chemistry and the meticulous control of various synthesis parameters. These parameters collectively determine the key structural attribute of the final product: the Degree of Substitution (DS).

1.1. The Chemistry Of Carboxymethylation: Williamson Ether Synthesis

Williamson ether synthesis is the method by which CMS is created, and is one of the earliest organic syntheses of ethers. The synthesis itself is typically performed under heterogeneous conditions where granular starch is placed into a liquid medium.^2,4 The synthesis occurs in two stages.

1. Alkali treatment: The hydroxy functionality of the AGUs in the starch polymer is activated or converted into the sodium starch alkoxide (NSSA) form, by using sodium hydroxide (NaOH) as the alkali. Once the sodium starch alkoxide is formed, the reaction is in equilibrium, making it very reactive and allowing it to act as the nucleophile in the subsequent step of etherification after the removal of water from St.-NaOH.^2,4,16

2. Etherification: In an etherification reaction, the starch alkoxide reacts through a nucleophilic substitution process with an etherifying agent. Ethereal agents used include sodium monochloroacetate (SMCA, ClCH2COONa) or monochloroacetic acid (MCA, ClCH2COOH).^2,4,16 In this step, the alkoxide attacks the carbon atom of the electrophilic carbon (attached to the Chloro atom), and forms a new functional group called a carboxymethyl ether. The result of the etherification step is sodium carboxymethyl starch, in addition to sodium chloride (NaCl) as a by-product.

St−ONa++ClCH2COONa→St−O−CH2COONa+NaCl

The major concern during this step is to minimize the influence of an unwanted side reaction by utilizing the sodium hydroxide (NaOH) reagent. Bio-reaction to sodium hydroxide (NaOH) and sodium monochloroacetate (SMCA) alone produces sodium glycolate (HOCH2COONa) and sodium chloride (NaCl); therefore, both the base and etherifying ingredient have an indirect impact on the overall reaction efficiency and affect the degree of substitution (DS) for the product.^2,4,15,16

1.2. Critical Synthesis Parameters and Their Influence On Product Attributes

The synthesis of CMS is a multi-variable optimization process where each parameter must be carefully controlled to achieve a product with the desired DS and functional properties. The interplay between these variables determines the balance between the desired etherification reaction and the competing side reaction, ultimately defining the quality of the final excipient.^1,4

Table 1: Influence of Synthesis Parameters on CMS Properties^1,2,4,15

1.3. The Degree of Substitution (DS): A Critical Quality Attribute

Degree of Substitution is really the key factor that sets each grade of CMS apart and shapes how it works as an excipient. Basically, it’s the average number of hydroxyl groups on every anhydroglucose unit (AGU) of the starch that get swapped out for carboxymethyl groups^2,4. Each AGU has three hydroxyl spots—at C2, C3, and C6—so the absolute highest DS you can get is 3.0.^2,4,15 But here’s the thing: those three positions aren’t equally reactive. Most research points to C2 getting substituted first, then C6, and finally C3.DS isn’t just a number on a chart.^4,15,16 It connects directly to how CMS behaves—higher DS means it grabs onto water better, dissolves more easily in cold water, swells up more, and carries a stronger negative charge. That kind of flexibility is useful. You end up with a whole spectrum of products. For everyday food and industrial uses, CMS usually has a low DS, around 0.3 or less. But if you need something with serious solubility and viscosity, you can push the DS up to 0.7 or even 1.5 for special applications. So, DS isn’t just a technical detail; it’s a critical quality marker that manufacturers need to nail down and double-check in the final product, just to make sure everything works the way it should.

1.4. Advanced Analytical Techniques For Structural Characterization

A suite of analytical techniques is employed to confirm the successful synthesis of CMS and to characterize its molecular and supramolecular structure.

• FTIR (Fourier-transform Infrared Spectroscopy): It is a quick and reliable method used to verify that carboxymethyl has been added, demonstrated by the emergence of new and distinct strong absorption bands that do not exist in unmodified starch. Many of these bands are associated with the respective vibrational motions of carboxylate ions (−COO−), which include one strong peak around 1600 cm (−1), indicating the asymmetric stretching mode, and another distinct peak near 1420 cm (−1), indicative of symmetric stretching response.^4,15,21The existence and strength of each of these peaks confirm this carboxymethyl modification qualitatively.
• Nuclear Magnetic Resonance (NMR) Spectroscopy: Nuclear Magnetic Resonance spectroscopy (NMR ) is used to provide a solid understanding as well as complete quantitative data on structural characteristics.^4,15 The carbon atom of the functional group within the molecules, i.e., carboxymethyl groups, is an important signal in this method; it appears in a very specific region of the spectrum (around 178.5 ppm), where native starches do not have any signal.^15,17,18 This gives us definitive proof that the starch has been carboxymethylated. Methods that allow for the identification of specific carbon atoms in the glucose molecule at positions C2, C3, and C6, can also be used after complete depolymerization of the polymer using ¹H and ¹³C NMR techniques; this will give us more accurate measurements of the overall DS.
• X-Ray Diffraction (XRD): The crystalline structure of native starch granules can be determined from their XRD patterns; these patterns typically show peaks associated with each type of starch: A-type for cereals, and B-type for tubers.^1,3 During the carboxymethylation process, starch granules are treated with an alkaline solution and additionally, bulky substituent groups are formed within their structure, causing a disruption of the previously established ordered crystalline arrangement. With CMS, the XRD analysis typically indicates that there has been a significant reduction in the intensity of these crystalline peaks. Therefore, showing an overall decrease in the level of crystallinity. The transition from semi-crystalline to a more amorphous structure is the most significant factor contributing to the improvement in the hydration and solubility of CMS.^2,4
• Scanning Electron Microscopy (SEM): The impact of the chemical modifications on morphology and surface characteristics of starch granules is evaluated by using Scanning Electron Microscopy (SEM).^4,15,21 Essentially, SEM shows a visual data regarding how changes will affect the physical characteristics of starch. Scanning electron micrographs (SEM) provides data about the surface texture of starch granules. Native starch granules appear smooth, oval, or polyhedral. However, granules produced from the chemical modification of starch (CMS) exhibit many distinguishing features as a result of the strong alkaline conditions utilized for synthesis.^4,15 Some of the changes will manifest as pits, indentations, shrinkage, or partial fragmentation/collapse in the granular structures. These morphological changes result in increased surface area and therefore contribute to the enhanced hydration kinetics of CMS compared with native starch.

2. Physicochemical Properties and Their Pharmaceutical Relevance

Carboxymethylation chemically modifies starch. Physical and chemical changes will occur as a result of this modification.² These changes account for the improved function and flexibility of carboxymethyl starch (CMS) as a pharmaceutical excipient. The change from a "water-fearing", crystalline polymer into a "water-loving", amorphous form is the basis for the broad number of applications for CMS, such as fast disintegration of tablets and slow release of drugs.^1,2,4

2.1. Solubility, Hydration, And Swelling Dynamics

The most fundamental change imparted by carboxymethylation is the dramatic increase in the polymer's interaction with water.

• Solubility: The reason native starch is often thought of as an insoluble material in water is due to the many strong intermolecular hydrogen bonds that maintain their semi-crystalline polymer chain network structures in granular form.^3,4,15 When carboxymethyl groups are introduced to the starch structure, the hydrogen bonds are disrupted, allowing for electrostatic repulsion between the negative charges on the two different anionic polymer chains.^2,4 With the increasing Degree of Substitution (DS), CMS will become more and more soluble in cold water. This property is critical for using it as a binder for wet granulation processes; using it as a thickening agent in a variety of aqueous solutions; and using it to form a drug delivery matrix for certain drugs.^2,8
• Swelling Power and Hydration: Carboxymethyl Starch (CMS) has a far greater capacity to absorb water and swell than native starches, even in grades that are not completely soluble (for example, cross-linked Sodium Starch Glycolate).^2,4As soon as it comes into contact with water, the high ratio of amorphous polymer networks becomes saturated; and therefore, due to an increase in the amount of hydrophilicity from the carboxymethyl groups, CMS will take up water quickly, resulting in significant swelling.^2,4,13 Additionally, the carboxymethyl groups contain ions that will provide an electrical charge to the carboxylate groups, providing an electrostatic repulsive force acting on the polymer chains. The forces acting upon the polymer chain will cause the polymer to separate and swell many times larger than its original size.^2,4,13 Moreover, CMS as a superdisintegrant has a significantly faster swelling rate to its peak viscosity than is seen with native starch. The rapid and large swellings of CMS are the basis for its use as a superdisintegrant.
• Water Holding Capacity: Due to increased hydration, the water holding/water absorption ability of CMS is also increased.^2,4,15 In addition, CMS is hygroscopic, meaning that it tends to absorb moisture from the environment. CMS's ability to hold water influences its efficiency as a disintegrant; but this means that you must keep it in a properly sealed container to prevent caking or pre-hydrating, both of which will adversely affect its functionality as a disintegrant.

2.2. Rheological Profile: Viscosity, Gelation, And Non-Newtonian Behavior

The formation of viscous solutions and gels with complicated rheological properties due to the interaction between CMS and water is paramount in applications involving liquid and semi-solid formulations.^3,9

Viscosity: CMS is an effective viscosity-increasing agent capable of producing very viscous solutions or pastes in very small (low) amounts of polymer concentration (low amount of polymer by weight). The extreme viscosity of CMS solutions is a result of inter-chain entanglement and the volume occupied by swollen, hydrated polymer chains. The viscosity of CMS solutions is a function of a variety of factors: Concentration: the viscosity of CMS solutions will increase with the increase in polymer concentration.³

Temperature: as a rule, the viscosity of CMS solutions will decrease significantly at elevated temperatures due to the increase in thermal energy that results in increased polymer chain flexibility, thus reducing the size of macromolecular coils.³ The degree of substitution (DS) has a non-monotonic relationship with dynamic viscosity in concentrated polymer solutions. While dynamic viscosity generally decreases as DS increases, this phenomenon can be attributed to increased electrostatic repulsion between polymer molecules and their surrounding environment as charge densities increase.^4,15 Therefore, at higher DS values, the polymers exist primarily in a relatively rigid, simply extended (as compared to less structured conformations) form, so there are less frequent intermolecular and intramolecular electrostatic interactions and fewer entanglements resulting in decreased viscosity.

Non-Newtonian Behavior: concentrated aqueous solutions of CMS are not simple Newtonian fluids. They exhibit pseudoplastic (shear-thinning) non-Newtonian behavior. The apparent viscosity of a concentrated solution of CMS decreases as the applied shear rate is increased.^3,9 Under conditions of rest and/or low shear, the entangled polymer chains create a high viscosity (an entangled state). As a result of the application of large amounts of shear (e.g. stirring and pumping), the polymer chain orientation in the flow direction, the number of entanglements diminishes, and therefore, the viscosity decreases. This is a desirable property in pharmaceuticals and cosmetics such as lotion and cream which should be thick and stable in the container and easily spreadable on the application.

Gel formation: One aspect of the characteristics of CMS pastes, are that they are very cohesive, meaning this characteristic will create a tendency for them to form gels.^1,10,13 The ability to form gels is utilized to serve as a stabilizer and to hold in suspension insoluble materials. This ability to form gels is also the basis for hydrophilic matrix tablets for sustained release of drug molecules; when the tablet is in contact with water, the gel surface formed on the outer layer of the tablet provides the barrier for diffusion of the active ingredient of the tablet.^10,13

2.3. Powder Characteristics and Compressibility

For applications in solid dosage forms, the physical properties of the CMS powder are as important as its behavior in solution.⁴

• Flow Properties: The flow characteristics of CMS powder after the modification process are equally as important as the solubility behaviour of CMS in solution when considering solid dosage formulation (tablet). According to studies, CMS will have better flow characteristics than native starch when comparing the two, as evidenced by a lower angle of repose with higher Carr's Index and Hausner's Ratio (greater than 1.3).^2,4 Consistent good powder flow is required for uniform die filling during high-speed compression of tablets to ensure that tablets created from the same batch will be uniform in weight and deliver specific dosages accurately.⁴
• Compressibility: When CMS is pregelatinized (cooked and dried), it has good compressibility properties. This means that CMS can be compressed into strong, durable tablets with less force and risk of damage to the active pharmaceutical ingredient (API).^4,5 In turn, this makes CMS suitable for direct compression, which is a more efficient and less costly way to produce tablets than wet granulation.^1,10,13
• Bulk and Tapped Density: Generally, the density of the powdered protein can be influenced by both the dry weight of the powder (DW) and the manner in which the protein was modified (e.g., through an acid treatment). Results from studies have demonstrated that the addition of DW led to an increase in powder density due to the altered packing arrangement of the granules of protein after they were modified. Thus, these two variables are important when determining the appropriate capsule or tablet die size for the weight of the formulation of protein being used.

2.4. Thermal Stability and Structural Morphology

The chemical modification also imparts changes to the thermal and structural properties of the starch.

• Thermal Properties: Thermal Properties: The addition of carboxymethyl group to starch through carboxymethylation it will increase the thermal stability or heat resistance of starch and it will also decrease the time that is required to reach the hydrophilic phase (gelatinisation). This shows that starch with the carboxymethyl group attached can withstand temperatures higher than starch alone before to the degradation process and will lose crystalline structure.
• Crystallinity and Morphology: The morphology and crystallinity of starch granules will be affected by carboxymethylation, as determined by methods such as X-ray diffraction (XRD) and scanning electron microscopy (SEM). The semi-crystalline arrangement would be broken due to the carboxymethylation process, leading to an amorphous polymer structure. Consequently, the loss of crystallinity here leads to a greater degree of hydration and swelling than existed prior to its being modified through carboxymethylation. Additionally, carboxymethylation can cause a roughening of the starch granule surface, creation of indentations or partial fragmentation. Thus, the combination of increased surface area and disruption of its internal structure allows rapid or easier contact and interaction between starch granules and water, aiding in the starch granule's role as a pharmaceutical excipient.

3. Carboxymethyl Starch in Conventional Solid Dosage Forms

Carboxymethyl Starch is commonly used in the pharmaceutical industry as a solid dosage form. The properties of Carboxymethyl Starch can be engineered for either immediate release of the active ingredient or prolonged, controlled release of the active ingredient. The ability to achieve this dual function is indicative of the versatility of Carboxymethyl Starch and is based on one structural element that is key to this versatility - the ability to form cross-links.^2,10,13

3.1. The Superdisintegrant Function: Mechanisms of Action

When CMS is chemically cross-linked, it is referred to as Sodium Starch Glycolate (SSG) in the Pharmacopoeia. SSG is a leading example of a super disintegrant - a category of agents designed to rapidly break apart tablets/capsules into smaller pieces after they have entered into aqueous solutions.^2,4,13 The significant increase in the total surface area of dissolved drug available for absorption caused by the rapid disintegration of the drug products (typically a barrier to absorption) increases the potential rate of dissolution. SSG is highly effective when utilized at relatively low concentrations (usually between 2-8%), depending on the particular formulation of the drug product.^2,4,13 It should be noted that SSG disintegrates by an array of mechanisms rather than through a single mechanism; all of these mechanisms are dependent upon the synergistic interaction between numerous forces. Swelling as a Primary Mechanism of Action: The primary action of SSG is based on the property of swelling that occurs when it interacts with water. The swelling occurs at a very fast rate and grows to an enormous size, due to the polymer cross-links that allow for the absorption of several times its weight in water (up to 20 times its weight).^2,4,13 As the SSG particles swell excessively and rapidly, the volume of the SSG significantly increases the internal hydrostatic pressure of the compact tablet matrix. This high level of internal hydrostatic pressure serves as a mechanical force to break the cohesive bonds created between the raw materials that were compressed to form the tableted product, thereby causing the tablet to break apart.

• Secondary Mechanisms: As previously stated, swelling is the main mechanism responsible for disintegration; however, there are mechanisms that work together with swelling to improve both rate and efficiency of the disintegration process:
• Particle-Particle Repulsion - Due to the fact that SSG is an anionic polyelectrolyte, when in the neutral pH of the GI tract, the carboxymethyles (−COO−) at the ends of the polymer chains on the SSG will ionize creating a very high concentration of negatively charged molecules on adjacent SSG particles.⁴ This large concentration of negatively charged molecules creates a strong repulsive force between like charged particles which provides a third disruptive force which will help push apart the tablet matrix. This additional force is additive to the physical pressure created by swelling.⁴
• Wicking (Capillary Action) - Due to the porous, particulate structure of SSG, water enters the core of the compressed tablet very rapidly by means of capillary action.^2,4Wicking serves to quickly hydrate disintegrant particles that are dispersed throughout the tablet matrix and thus enable the mechanisms for swelling and repulsion to occur rapidly and in a uniform manner
• Deformation Recovery - Although not to as great an extent, the elastic deformation recovery of deformed and compressed SSG particles once wet also adds to the disintegration of the tablet by producing localized stresses to the tablet structure.⁴

The Critical Role of Cross-linking: The presence of chemical cross-links is the pivotal structural feature that enables the superdisintegrant function.^2,4,13 These cross-links act as intramolecular tethers, rendering the polymer insoluble in water. They prevent the individual polymer chains from dissolving and forming a viscous gel layer on the tablet's surface. Instead, the cross-links allow the particle to swell to a massive extent while maintaining its particulate integrity. Without cross-linking, the polymer would simply dissolve and form a viscous hydrogel, which would act as a barrier, impeding further water penetration and dramatically slowing or even preventing disintegration. Thus, cross-linking is the key that unlocks the explosive swelling potential of CMS for rapid disintegration.

3.2. Performance as A Tablet Binder And Filler

The primary use of cyclodextrin-based microparticles (CMS) is for disintegration of agglomerated powders. However, some CMS can be used as effective binding agents between ingredients to give the tablet mechanical properties to hold all ingredients intact.³ It might sound confusing that CMS can serve both functions (as disintegrators or binders), but it is often an example of differences in DS (degree of substitution) or source materials when it comes to CMS with different characteristics. For instance, one study compared compressed tablets manufactured using CMS as a binder to those using unmodified starch and found that CMS tablets are more durable and exhibit less breakage than unmodified starch tablets.^3,8 By using CMS in solution/paste form, compared to powdered form, the effect will be significantly enhanced on the quality of compressed tablets and results in potentially very strong tablets using only high-amylose sodium carboxymethyl starch (HASCA) as the binding agent because of the amorphous nature of HASCA polymer and how the HASCA particles can undergo fusion under the high compressive forces associated with the compression process.^1,10,13

3.3. Role in Immediate-Release VS. Controlled-Release Formulations

The functional role of CMS in a solid dosage form is fundamentally determined by the degree of cross-linking, creating a clear dichotomy in its application.

Immediate Release Formulations: An Immediate Release formulation (IR) tablet's objective is to deliver medication as quickly as possible using Sodium Starch Glycolate as its excipient. Sodium Starch Glycolate serves as an exclusive "superdisintegrant,” helping to accelerate the breaking apart of the tablet to facilitate rapid dissolution of the drug, followed by the rapid onset of action.

Controlled Release Formulations: In the case of CMS, after it has undergone significant de-cross linking (the complete calcification of the polymer), there is a change in function.^10,13 In this instance, the polymer becomes water-soluble. When it comes into contact with gastrointestinal fluids, it will not swell and rupture as is typically the case with other types of polymers. Rather, when it contacts GI fluid, the outermost chains of CMS will begin to hydrate, dissolve, and create a gel-like layer on top of the CMS tablet. This layer creates a diffusive barrier to penetrating moisture into the core of the tablet as well as controlling the rate at which dissolved drug is released from the tablet's matrix to the surrounding media. As the outer gel layer of CMS begins to dissolve (erode), it will expose another layer of gel beneath to continue the controlled release of the drug from the matrix, thereby extending the time period for sustained release of the drug. Hydrophilic matrix tablets are a typical example of the method of sustained release and how this action is achieved. A special substance for creating prolonged release matrices is high amylose CMS. Additionally, uncross linked CMS can work in concert with other hydrophilic polymers, including HPMC, to formulate systems with more precise control over drug release patterns by creating a more rigid and regulated gel matrix.^10,13 The Carboxymethyl Starch platform's versatility is demonstrated by its capacity to switch from being an accelerator and a retardant of drug release due to a single structural alteration

Table 2: Functional Divergence of Carboxymethyl Starch in Solid Dosage Forms ^2,5,10,13

4. Application in Liquid and Semi-Solid Formulations

5. Emerging Frontiers: CMS In Novel Drug Delivery Systems (DDS)

The unique physicochemical properties of Carboxymethyl Starch, particularly its anionic nature and tunable solubility, have positioned it as a "smart" polymer at the forefront of research into advanced drug delivery systems.^6,10,11 Its ability to respond to physiological stimuli like pH and to interact with biological tissues makes it an ideal candidate for creating sophisticated carriers that can deliver therapeutic agents to specific sites in the body, control their release over time, and improve their overall efficacy.

5.1. PH-Responsive Systems for Targeted Drug Delivery

The characteristic that differentiates CMS from other intelligent polymers is its strong responsiveness to changes in pH. This characteristic of CMS is related to its carboxylic acid functional groups (−COOH) added during synthesis, which have a pKa in the neighbourhood of 4.5.^6,10,11 The location of this pKa value is notable because it is located between the low pH of the stomach (1.2-3.0) and the higher near neutral to slightly alkaline pH of the intestine (6.8-7.4).^11,14,18 The source of CMS's pH-responsive mechanism is the ionization state of the carboxyl groups is determined by the pH of the surrounding media. In an acidic medium (pH< pKa): the carboxyl groups in the stomach are flourished by their respective protons and therefore exist mainly as protonated groups (−COOH). This neutralised state allows for a high degree of hydrogen bonding between the polymer chains and makes the CMS less hydrated and compact, and with decreased permeability.^11,14 The "collapsed" state also functions as protection for the encapsulated drug against the aggressive acidic environment of the stomach and thus slows down the liberation of the drug. In neutral or alkaline (pH greater than pKa) environments, the dosage form's transition to a higher pH due to the larger physiological (pH > 7) levels of the intestines leads to the deprotonation of the carboxyl groups^11,14. Therefore, the polymer becomes anionic in nature (−COO−). Because the high density of negative charge results in a strong electrostatic repulsion between the carboxylate groups in addition to overcoming the hydrogen bonding that form between the carboxylate groups, there is an increased amount of moisture present within the polymer causing a rapid hydration and swelled state for the polymer.^11,14 thus, providing significantly higher amounts of permeability and increased rates of release of drug that was encapsulated within the polymeric network.

5.2. Mucoadhesive Formulations for Enhanced Bioavailability

Mucus-rich Glycoproteins—Mucins—& Their Role as an Adhesive, Allowing CMS dosages to Adhere to Mucosal Surfaces, Increasing Bioavailability by Increasing Duration of Drug Contact with Mucosal Surfaces. Mucoadhesion also enhances bioavailability due to the nature of the mucosal iodine-containing compound (CMS). The carboxyl group present in CMS forms strong interactions with sialic acid residues of mucins (which have a negatively charged surface) by creating hydrogen bonds as well as through electrostatic attraction (the carboxyl groups are -COO- which is positively charged).^11,14 Because these adhesive interactions allow for greater residence time at the absorption site of CMS, it has been shown that CMS containing dosage forms provide a means of increasing the total amount of drug available for distribution throughout the body, thereby enhancing the overall bioavailability of a given dosage form.^6,11,14

5.3. Nanotechnology-Based Carriers: Nanoparticles, Microspheres, And Nanocomposites

CMS is an excellent biomaterial for the fabrication of nano- and micro-sized drug delivery vehicles, owing to its biocompatibility, biodegradability, and the presence of reactive functional groups for further modification.^6,10

• Nanoparticles and Microspheres: Polyelectrolyte complexation, for example, of the cationic polymer chitosan with CMS nanoparticles, can be formed through a variety of methods including methods of emulsification.^6,10,14 These various types of nanoparticle systems provide a carrier for drug encapsulation and retention for reducing or preventing drug degradation during transit through the plasma, as well as a controlled release of drugs during their expulsion from the tissues. Through the use of CMS–chitosan nanoparticles, the controlled and delayed release of 5-aminosalicylic acid has been achieved and used for the treatment of inflammatory bowel disease.^11,14 CMS–chitosan microspheres have also been developed with a range of DSs, giving them the ability to optimize oral delivery of hydrophobic anticancer drugs, such as doxorubicin and 5-fluorouracil, with controlled release using a pH-dependent mechanism and utilizing a model of a sensor.
• Nanocomposites: In the future, CMS-based carriers will become innovative by creating composite multifunctional systems through combining the properties of both CMS and other materials. This has led to the development of new carriers that possess many enhanced properties, including a newly engineered pH responsive nanocarrier formulated for delivery of a curcumin anticancer agent from a composite of CMS, polyethylene glycol (PEG), and gamma-alumina nanoparticles^11,12. The CMS will serve as the pH-responsive release trigger, and PEG will give it "stealth" properties for evading the immune system, while the inorganic nanoparticles will provide the structural backbone..

6. Comparative Analysis and Formulation Considerations

The selection of an excipient for a pharmaceutical formulation is a critical decision that impacts manufacturability, stability, and clinical performance.^2,4 While Carboxymethyl Starch offers remarkable versatility, a formulator must understand its performance relative to other common excipients and be aware of how its functionality can be influenced by other ingredients and by the manufacturing process itself.

6.1. Performance Benchmark: CMS VS. Other Superdisintegrants

Sodium Starch Glycolate (SSG) is positioned as the superdisintegrant in the marketplace, competing against Croscarmellose Sodium (CCS), a cross-linked derivative of cellulose, and Crospovidone, which is a synthetic cross-linked polymer of N-vinyl-2-pyrrolidone.^2,4,5Each of these materials has its own properties and is very effective as a disintegrant; however, the ways in which they operate are different as well as their relative costs and efficacy.

Table 2: Comparative Properties of Common Superdisintegrants^2,4,5